Application no. and date | 15728222.9 (espacenet) (Federated) (European Patent Register), 20150410 | Patent/reg. no. and date | DK/EP 3129018, 20191023 | Publication date | 20170215 | Priority no. and date | US 201461978335 P, 20140411 | EP pub. no. and date |
EP 3129018 20170215 | Effective date | | Applicant/owner | CymaBay Therapeutics, Inc., 7575 Gateway Boulevard, Suite 110
Newark, CA 94560, US | Applicant ref. no. | P81905358DK00E | Inventor | ROBERTS, Brian, 7575 Gateway Boulevard, Suite 110
Newark, CA 94560, US, WANG, Xueyan, 7575 Gateway Boulevard, Suite 110
Newark, CA 94560, US, CHOI, Yun-Jung, 7575 Gateway Boulevard, Suite 110
Newark, CA 94560, US, KARPF, David, 7575 Gateway Boulevard, Suite 110
Newark, CA 94560, US, MARTIN, Robert, 7575 Gateway Boulevard, Suite 110
Newark, CA 94560, US, MCWHERTER, Charles A., 7575 Gateway Boulevard, Suite 110
Newark, CA 94560, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/33 (2006.01) , A61P 1/16 (2006.01) | Title | Behandling af NAFLD og NASH | Int. application no. | US2015025416 | Int. publication no. | WO2015157697 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|